Patents Assigned to KYMAB LTD.
  • Animal models and therapeutic molecules
    Patent number: 11812731
    Abstract: The invention discloses methods for the generation of chimaeric human—non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanised antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods.
    Type: Grant
    Filed: October 17, 2013
    Date of Patent: November 14, 2023
    Assignee: Kymab Ltd.
    Inventors: Allan Bradley, E-Chiang Lee, Qi Liang, Wei Wang, Anais Legent, Ian Kirby
  • Transgenic Animals
    Publication number: 20140331344
    Abstract: The present invention relates inter alia to fertile non-human vertebrates such as mice and rats useful for producing antibodies bearing human variable regions, in which endogenous immunoglobulin chain expression has been inactivated.
    Type: Application
    Filed: May 3, 2013
    Publication date: November 6, 2014
    Applicant: Kymab Ltd.
    Inventor: Kymab Ltd.
  • Transgenic Animals
    Publication number: 20130243759
    Abstract: The present invention relates inter alia to fertile non-human vertebrates such as mice and rats useful for producing antibodies bearing human variable regions, in which endogenous antibody chain expression has been inactivated.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 19, 2013
    Applicant: KYMAB LTD.
    Inventors: Glenn A. Friedrich, E-Chiang Lee